Cary Street Partners’s Zimmer Biomet ZBH Stock Holding History

Cary Street Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,591	Closed	-$144K	–	1124
2026 Q1	$144K	Buy	+1,591	New	+$146K	﹤0.01%	878
2025 Q4	–	Sell	-1,882	Closed	-$185K	–	1017
2025 Q3	$185K	Sell	1,882 -6,203	-77%	-$615K	﹤0.01%	806
2025 Q2	$737K	Sell	8,085 -432	-5%	-$41.8K	0.02%	465
2025 Q1	$964K	Buy	8,517 +4	+0%	+$428	0.03%	398
2024 Q4	$899K	Buy	+8,513	New	+$913K	0.03%	402

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Cary Street Partners's ZBH Position: Q2 2026 in Review

Cary Street Partners sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 1,591 shares — an estimated $144K sold.

Cary Street Partners first reported a position in ZBH in Q4 2024 and held it in 5 quarters. The position peaked at $964K in Q1 2025. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Cary Street Partners reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Cary Street Partners sold 1,591 Zimmer Biomet shares in Q2 2026, an estimated $144K.
Cary Street Partners first reported a position in Zimmer Biomet in Q4 2024 and held it in 5 quarters.
Cary Street Partners's Zimmer Biomet position peaked at $964K in Q1 2025.
150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.